Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE).

I Silverberg, Jonathan; Bissonnette, Robert; Kircik, Leon; F Murrell, Dedee; Selfridge, Andrew; Liu, Kris; Ahluwalia, Gurpreet; Guttman-Yassky, Emma

doi:10.1111/jdv.18914

Public

Efficacy and safety of etrasimod, a sphingosine 1-phosphate receptor modulator, in adults with moderate-to-severe atopic dermatitis (ADVISE).

Shared by NobleBlocks on Jul 1, 2023 • 12:00 AM UTC

Authors:

Jonathan I Silverberg

Robert Bissonnette

Leon Kircik

Abstract

BACKGROUND: Etrasimod is an oral, selective, sphingosine 1-phosphate (S1P) receptor1,4,5 modulator in development for immune-mediated inflammatory disorders. Efficacy and safety of orally administered S1P receptor modulation in atopic dermatitis (AD) have not yet been examined. OBJECTIVE: To assess ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!